Concept

Clostridioides difficile

Clostridioides difficile (syn. Clostridium difficile) is a bacterium that is well known for causing serious diarrheal infections, and may also cause colon cancer. It is known also as C. difficile, or C. diff (siː_dɪf), and is a Gram-positive species of spore-forming bacteria. Clostridioides spp. are anaerobic, motile bacteria, ubiquitous in nature and especially prevalent in soil. Its vegetative cells are rod-shaped, pleomorphic, and occur in pairs or short chains. Under the microscope, they appear as long, irregular (often drumstick- or spindle-shaped) cells with a bulge at their terminal ends (forms subterminal spores). Under Gram staining, C. difficile cells are Gram-positive and show optimum growth on blood agar at human body temperatures in the absence of oxygen. C. difficile is catalase- and superoxide dismutase-negative, and produces up to three types of toxins: enterotoxin A, cytotoxin B and Clostridioides difficile transferase (CDT). Under stress conditions, the bacteria produce spores that are able to tolerate extreme conditions that the active bacteria cannot tolerate. Clostridioides difficile is an important emerging human pathogen; according to the CDC, in 2017 there were 223,900 cases in hospitalized patients and 12,800 deaths in the United States. Although C. difficile is commonly known as a hospital and antibiotic associated pathogen, at most one third of infections can be traced to transmission from an infected person in hospitals, and only a small number of antibiotics are directly associated with an elevated risk of developing a C. difficile infection (CDI), namely clindamycin, fluoroquinolones and cephalosporins. The majority of infections are acquired outside of hospitals, and most antibiotics have similar elevated risk of infection on par with many non-antibiotic risk factors, such as using stool softeners and receiving an enema. Clostridioides difficile can also become established in the human colon without causing disease. Although early estimates indicated that C.

Official source

https://en.wikipedia.org/wiki/Clostridioides_difficile

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related lectures (6)

Engineering with Bacteria: Fecal Transplant Therapy

Delves into fecal transplant therapy, the brain-gut connection, and engineering applications of bacteria.

Microbiota and Antibiotics Impact

Explores the influence of microbiota and antibiotics on health, discussing bacterial resistance, replication, and the microbiome's role in bodily functions.

Bacteria: Structure, Function, and Medical Applications

Covers the structure and function of bacteria, their roles in health, and medical applications like fecal transplants.

Related publications (9)

Severe vitamin K deficiency-associated coagulopathy triggered by Clostridioides difficile infection and antibiotic-associated dysbiosis: A case report and literature review

Purpose Clostridioides difficile infection (CDI) represents a major healthcare associated infection with potentially life-threatening complications. While gastrointestinal and systemic manifestations are well recognized, severe micronutrient deficiencies, particularly vitamin K deficiency are rarely described. We aimed to report a unique case of CDI-and antibiotic-associated dysbiosis and malabsorption leading to profound vitamin K deficiency and coagulopathy, thereby highlighting the clinical intersection

Springer Science and Business Media LLC2026

Chemical inhibition of a bacterial immune system

The rise of antibiotic resistance motivates a revived interest in phage therapy. However, bacteria possess dozens of anti-phage immune systems that confer resistance to therapeutic phages. Chemical inhibitors of these anti-phage immune systems could be employed as adjuvants to overcome resistance in phagebased therapies. Here, we report a class of chemical inhibitors that selectively inhibit type II Thoeris antiphage immune systems from diverse bacteria-including antibiotic-resistant pathogens, thereby sens

CELL PRESS2026

Competition against the intestinal microbiota selects for pathoadaptive traits in ESBL E. coli

The intestinal tract is a reservoir for Extended-Spectrum β-Lactamase (ESBL)-producing Escherichia coli. Asymptomatic gut colonization by these pathobionts represents a major risk for extraintestinal infections. Despite clinical relevance, the genetic basis of gut colonization by ESBL E. coli remains poorly understood. Here, we determined how the microbiota shapes the fitness landscape of diverse ESBL E. coli strains, defining the functional requirements for intestinal colonization. In microbiota-depleted h

openRxiv2026

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Official source

https://en.wikipedia.org/wiki/Clostridioides_difficile

About this result

Related lectures (6)

Engineering with Bacteria: Fecal Transplant Therapy

Delves into fecal transplant therapy, the brain-gut connection, and engineering applications of bacteria.

Microbiota and Antibiotics Impact

Explores the influence of microbiota and antibiotics on health, discussing bacterial resistance, replication, and the microbiome's role in bodily functions.

Bacteria: Structure, Function, and Medical Applications

Covers the structure and function of bacteria, their roles in health, and medical applications like fecal transplants.

Related publications (9)

Severe vitamin K deficiency-associated coagulopathy triggered by Clostridioides difficile infection and antibiotic-associated dysbiosis: A case report and literature review

Springer Science and Business Media LLC2026

Chemical inhibition of a bacterial immune system

CELL PRESS2026

Competition against the intestinal microbiota selects for pathoadaptive traits in ESBL E. coli

openRxiv2026

Related people (14)

Johan Auwerx

Johan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways. Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards. Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.

Jieping Zhu

Teaching & PhD PhD Students Morgane Elodie Marie Delattre, Paul Jean Gri, Clément Paul Adrien Rols, Yun Hao Shawn Teh Past EPFL PhD Students Jean-Baptiste Gualtierotti, Ala Bunescu, Thomas Buyck, Olivier Wagnières, Minh Tu Ha, Dylan Jean Robert Dagoneau, Antonin François Roland Clemenceau, Cyril Piemontesi, Nicolas David Gaeng, Mathias Mamboury, Raphaël Beltran, Balázs Budai, Teerawat Songsichan, Alexandre Julien Florent Leclair, Bastien Delayre, Rémi Julien Sylvain Andres, Dina Boyarskaya, Rémi Lavernhe,

Bhanu Kiran Pothineni

Rizlan Bernier-Latmani

HIGHER EDUCATION Summer course: Advances in Genome Technology and Bioinformatics Course at the Marine Biology Laboratory in Woods Hole, MA. October 2005. Ph.D. 2001 Civil and Environmental Engineering, Stanford University, CA (Advisor, Jim Leckie, Biodegradation of uranyl (UO22 )-complexed citrate and implications for uranyl mobility in the subsurface) M.S. 1995 Civil and Environmental Engineering, Stanford University, CA B.S. 1993 Natural Resources with Honors, Cornell University, Ithaca, NY PROFESSIONAL EMPLOYMENT 2013-present Associate professor with tenure, School of Architecture, Civil and Environmental Engineering, Swiss Federal Institute of Technology, Lausanne 2005-2013 Assistant professor tenure track, School of Architecture, Civil and Environmental Engineering, Swiss Federal Institute of Technology, Lausanne 2001-2005 Post-Graduate Researcher, Scripps Institution of Oceanography, La Jolla, CA (PI: Brad Tebo) 1995-2001 Graduate Research Assistant, Stanford University (Advisor: Jim Leckie) RESEARCH INTERESTS Gemicrobiology, metal-bacteria interactions, biological reduction and oxidation of metals, biological nanoparticle formation; Characterization of microbial communities in terrestrial environments; Using genomic, microscopic and spectroscopic tools to understand metal transformations by microorganisms. ACADEMIC HONORS Rotary Foundation University Professor grant, 2004. Swiss National Science Foundation Post-doctoral Fellowship, 2001. Leon B. Reynolds Memorial Scholarship in the School of Engineering at Stanford University, 1995-96. Graduated with Honors from Cornell University, 1993. BIBLIOMETRY http://www.researcherid.com/rid/E-4398-2011 ResearcherID: E-4398-2011

Henning Paul-Julius Stahlberg

Mission We use high-resolution cryo-electron microscopy to study neurodegeneration and other protein systems. We also develop novel imaging technology in the areas of electron microscopy hardware and applications, sample preparation, data collection schemes, and data analysis software systems. The Stahlberg group is supported by the University of Lausanne, Faculty of Medicine and Biology, and by the EPFL, Faculty of Basic Sciences, Physics Institute. The LBEM is a research laboratory of both UNIL and EPFL.

Julien Bortoli Chapalay

Marc Chambon

Teaching & PhD Courses Methods: from disease models to therapy BIOENG-518 This course will describe methods underlying translational approaches from disease modeling and characterization to therapeutic applications. The presented techniques will be complemented by hands-on rotations in the technological platforms of the School of Life Sciences.

Josephine Lederballe Meibom

Laure Menin

Expertise Mass spectrometryLC-MS / GC-MSBiochemistryProteomicsToxinologyDrug discovery Teaching & PhD Courses Mass spectrometry, principles and applications CH-728 The goal is to provide students with a complete overview of the principles and key applications of modern mass spectrometry and meet the current practical demand of EPFL researchers to improve structural analsis of molecules. Numerous instrumental aspects of mass spectrometry are described.

Jérôme Chenal

Expertise Urban DesignUrban PlanningUrban ManagementPublic SpaceHousingDevelopment StudiesVisual Anthropology Mission Director of CEAT Director of Excellence in Africa Center Affiliate professor at UM6P Teaching & PhD Past EPFL PhD Students Stéphanie Hasler, Rémi Jaligot, Armel Firmin Kemajou Mbianda, Martí Bosch Padrós, Andrea Salmi, Vitor Pessoa Colombo, Akuto Akpedze Konou, Rim Mrani Past EPFL PhD Students as codirector Marc Antoine Messer, Alexandre Rigal Courses Urban planning in the South PE

Related concepts (11)

Colitis

Colitis is swelling or inflammation of the large intestine (colon). Colitis may be acute and self-limited or long-term. It broadly fits into the category of digestive diseases. In a medical context, the label colitis (without qualification) is used if: The cause of the inflammation in the colon is undetermined; for example, colitis may be applied to Crohn's disease at a time when the diagnosis is unknown, or The context is clear; for example, an individual with ulcerative colitis is talking about their disease with a physician who knows the diagnosis.

Clostridioides difficile infection

Clostridioides difficile infection (CDI or C-diff), also known as Clostridium difficile infection, is a symptomatic infection due to the spore-forming bacterium Clostridioides difficile. Symptoms include watery diarrhea, fever, nausea, and abdominal pain. It makes up about 20% of cases of antibiotic-associated diarrhea. Antibiotics can contribute to detrimental changes in gut microbiota; specifically, they decrease short-chain fatty acid absorption which results in osmotic, or watery, diarrhea.

Toxic megacolon

Toxic megacolon is an acute form of colonic distension. It is characterized by a very dilated colon (megacolon), accompanied by abdominal distension (bloating), and sometimes fever, abdominal pain, or shock. Toxic megacolon is usually a complication of inflammatory bowel disease, such as ulcerative colitis and, more rarely, Crohn's disease, and of some infections of the colon, including Clostridium difficile infections, which have led to pseudomembranous colitis.